Mark Bradley

Board Of Directors at Biproxi

Mark Bradley is an accomplished executive with extensive experience in leadership roles across various organizations. Since January 2013, Mark has served as the CEO of North Shore Capital LLC. In addition, Mark has been a member of the Board of Directors for Biproxi since October 2018 and an Executive Advisory Board Member and investor at TransMed7, LLC since November 2017. Mark's commitment to education and engineering is reflected in the role as Executive Board Member for the SMU Lyle School of Engineering since May 2017. Previous leadership positions include Chief Operating Officer at GiddyUp from June 2020 to April 2023 and involvement with several advisory boards, including QuanticMind and Kennet Partners. Mark earned a Bachelor of Business Administration in Finance with an emphasis in Accounting from the SMU Cox School of Business, graduating in 1987.

Links

Previous companies

ChemDirect logo
AcademixDirect logo
GiddyUp logo
Kennet Partners logo

Org chart

This person is not in the org chart


Teams

This person is not in any teams